Citigroup Issues Positive Forecast for ProKidney (NASDAQ:PROK) Stock Price

ProKidney (NASDAQ:PROK – Get Free Report) had its target price hoisted by equities researchers at Citigroup from $6.00 to $9.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s targe…

Read Full Article →